Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Amortization of Deferred Charges (2024 - 2025)

OptimizeRx's Amortization of Deferred Charges history spans 4 years, with the latest figure at $174000.0 for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges fell 4.4% year-over-year to $174000.0; the TTM value through Sep 2025 reached $1.1 million, up 96.52%, while the annual FY2024 figure was $835000.0, 295.73% up from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was $174000.0 at OptimizeRx, down from $437000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $437000.0 in Q2 2025 and bottomed at $174000.0 in Q1 2025.